CVS Health Corporation
CVS
$63.80
$0.140.22%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.34% | 166.38% | -37.24% | -9.26% | 78.71% |
| Total Depreciation and Amortization | 8.72% | 7.33% | 2.03% | -4.58% | -6.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.31% | -90.99% | 207.19% | 410.59% | -72.75% |
| Change in Net Operating Assets | -5.83% | -106.77% | 87.22% | 1,547.76% | -3,237.91% |
| Cash from Operations | -35.04% | -70.23% | 8.54% | 108.76% | -148.74% |
| Capital Expenditure | -32.41% | 6.03% | -44.85% | 6.37% | -15.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,400.00% | -200.00% | -7,849.15% | -101,242.86% | 27.27% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.86% | 11.11% | -215.34% | 53.37% | 87.74% |
| Cash from Investing | -943.70% | 4.22% | -386.48% | -327.20% | 91.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,600.00% | 64.48% | -324.09% | -2,485.71% | 99.34% |
| Issuance of Common Stock | -14.63% | -24.69% | -52.94% | -67.68% | -62.39% |
| Repurchase of Common Stock | 99.67% | 50.00% | 50.56% | 0.48% | -21,800.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.34% | -7.30% | -7.43% | -7.89% | -8.94% |
| Other Financing Activities | -77.50% | -545.00% | -30.00% | 14.09% | -46.67% |
| Cash from Financing | 55.56% | 16.19% | 247.34% | 202.87% | 24.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.90% | -114.75% | -197.18% | 252.78% | -1,120.06% |
